Drugmakers suffer £8bn hit after RFK ousts America’s top vaccine official
Almost £8bn has been wiped off the value of the world’s biggest drugmakers after America’s leading vaccine official was ...
France attacks Trump ‘diktat’ on DEI
France has accused Donald Trump of “interference” after the White House demanded that European companies working with the US ...
Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
Another week of escalating tariff talks led to a slump across major U.S. stock market indices for the five-day trading period. The S&P 500 dropped nearly 3% for the week, with losses in three of the ...
Does the shingles jab slash your risk of dementia? Drugs giant GSK launches ground-breaking study that could save millions of Brits from developing the disease
The trailblazing study will use the data from up to 1.4million NHS patients to test whether its shingles vaccine reduces the ...
Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
GSK pushes UK government to give more access to health data, Bloomberg says
GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
World Business Council for Sustainable Development (WBCSD)4d
WBCSD and pharmaceutical companies release first sector Roadmap towards nature-positive action
The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...
Pharmabiz4d
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative: London, UK Thursday, March 27, 2025, 09:00 Hrs [I ...
MARKET WATCH: Could GSK jab lower risk of Dementia? Drugs giant to trial its shingles jab as a cure for the disease
GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...